跳至主要内容
临床试验/NCT02455778
NCT02455778已完成不适用

Effect of Intervention With Oral Cinnamon on Metabolic Profile and Body Composition of Asian Indians With Metabolic Syndrome in North India: A 16 Week Double Blind Placebo Control Trial

Diabetes Foundation, India1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
103
试验地点
1
主要终点
Fasting Blood Glucose

研究概览

简要总结

This double blind placebo control study with supplementation of oral Cinnamon is being conducted to test the hypothesis that in subjects with Metabolic Syndrome oral cinnamon may lead to improvement in body composition and metabolic parameters.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
25 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged between 25 -65 years
  • Subjects identified with any three of following:
  • Fasting blood glucose ≥100 mg/ dL
  • Waist circumference ≥ 90 cm ( males) ≥ 80 cm (females)
  • Triglycerides ≥ 150 mg/dL
  • High density lipoprotein cholesterol ≤ 40 mg/dL ( in males) , ≤ 50 mg/dL (in females)
  • Blood pressure Systolic BP ≥ 130 mm Hg
  • Diastolic BP ≥ 85 mm Hg
  • Subjects who were willing to participate in the study.
  • Subjects, if on medication for high blood pressure were stable and there was no change in the dosage for the past 3 months.

排除标准

  • Subjects suffering from other chronic diseases and metabolic complications such as cardiovascular disease, diabetes, renal disease, myocardial infarction and other endocrine disorders.
  • Subjects who were allergic to wheat flour and cinnamon.
  • Subjects who were on medication of anti dyslipidemic or hypoglycemic drugs.
  • Subjects who had undergone bypass procedure.
  • Subjects suffering from any debilitating disease such as tuberculosis, HIV etc.
  • Subjects suffering from uncontrolled hypothyroidism/ hyperthyroidism
  • Pregnant and lactating mothers

结局指标

主要结局

Fasting Blood Glucose

时间窗: baseline to 4 months

次要结局

  • HbA1c(baseline to 4 months)
  • Lipid profile(baseline to 4 months)
  • Body fat percentage(baseline to 4 months)
  • Blood pressure(baseline to 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr Anoop Misra

Director

Diabetes Foundation, India

研究点 (1)

Loading locations...

相似试验